Technicals for Concord Biotech Limited

Price Summary

Concord Biotech Limited's stock started trading at 1297.4 on 2026-07-01, climbed to 1314.5, fell to 1280.5, and closed -0.86% down at 1286.2, with 118423 shares traded.
Throughout the 52-week period, the stock hit a high of 1943.9 and a low of 1014.8.

Technicals

Support and Resistance: The price for CONCORDBIO at 1286.2 is supported by the 1261.9 level and faces resistance at 1337.7. This range indicates key levels where the price may find buyers near 1261.9 and sellers near 1337.7, defining a trading range.


Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for CONCORDBIO. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.


Bol. Bands: The BOLL BANDS is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.


Parabolic SAR: The PSAR for CONCORDBIO continues to indicate a bearish outlook, reinforcing a resistance level that could limit upward potential. This suggests that the market may remain under bearish control, with resistance acting as a barrier to significant upward movement.


Stochastic: The STOCHASTIC is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages suggests a bearish trend, but the wavering slopes of the 20 and 50 SMAs hint at a potential shift. This weakening momentum could indicate that the bearish trend for CONCORDBIO is losing steam, possibly leading to a bullish reversal in the near future. Investors should watch for signs of a market turnaround as the current downtrend shows signs of faltering.


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.